Covenant Health Palliative Institute, Edmonton, Alberta, Canada.
Human Nutrition Research Unit, Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada.
JAMA Surg. 2020 Oct 1;155(10):942-949. doi: 10.1001/jamasurg.2020.2497.
Given the risks of postoperative morbidity and its consequent economic burden and impairment to patients undergoing colon resection, evaluating risk factors associated with complications will allow risk stratification and the targeting of supportive interventions. Evaluation of muscle characteristics is an emerging area for improving preoperative risk stratification.
To examine the associations of muscle characteristics with postoperative complications, length of hospital stay (LOS), readmission, and mortality in patients with colon cancer.
DESIGN, SETTING, AND PARTICIPANTS: This population-based retrospective cohort study was conducted among 1630 patients who received a diagnosis of stage I to III colon cancer from January 2006 to December 2011 at Kaiser Permanente Northern California, an integrated health care system. Preliminary data analysis started in 2017. Because major complication data were collected between 2018 and 2019, the final analysis using the current cohort was conducted between 2019 and 2020.
Low skeletal muscle index (SMI) and/or low skeletal muscle radiodensity (SMD) levels were assessed using preoperative computerized tomography images.
Length of stay, any complication (≥1 predefined complications) or major complications (Clavien-Dindo classification score ≥3), 30-day mortality and readmission up to 30 days postdischarge, and overall mortality.
The mean (SD) age at diagnosis was 64.0 (11.3) years and 906 (55.6%) were women. Patients with low SMI or low SMD were more likely to remain hospitalized 7 days or longer after surgery (odds ratio [OR], 1.33; 95% CI, 1.05-1.68; OR, 1.39; 95% CI, 1.05-1.84, respectively) and had higher risks of overall mortality (hazard ratio, 1.40; 95% CI, 1.13-1.74; hazard ratio, 1.44; 95% CI, 1.12-1.85, respectively). Additionally, patients with low SMI were more likely to have 1 or more postsurgical complications (OR, 1.31; 95% CI, 1.04-1.65) and had higher risk of 30-day mortality (OR, 4.85; 95% CI, 1.23-19.15). Low SMD was associated with higher odds of having major complications (OR, 2.41; 95% CI, 1.44-4.04).
Low SMI and low SMD were associated with longer LOS, higher risk of postsurgical complications, and short-term and long-term mortality. Research should evaluate whether targeting potentially modifiable factors preoperatively, such as preserving muscle mass, could reverse the observed negative associations with postoperative outcomes.
鉴于术后发病率及其随之而来的经济负担和对接受结肠切除术患者的损害,评估与并发症相关的风险因素将允许风险分层和针对支持性干预措施。肌肉特征的评估是改善术前风险分层的一个新兴领域。
检查肌肉特征与接受结肠癌治疗的患者的术后并发症、住院时间(LOS)、再入院和死亡率之间的关联。
设计、地点和参与者:这是一项基于人群的回顾性队列研究,在 Kaiser Permanente Northern California 的 1630 名被诊断患有 I 期至 III 期结肠癌的患者中进行,该系统是一个综合性医疗保健系统。初步数据分析于 2017 年开始。由于主要并发症数据是在 2018 年至 2019 年之间收集的,因此使用当前队列进行的最终分析是在 2019 年至 2020 年之间进行的。
使用术前计算机断层扫描图像评估低骨骼肌指数(SMI)和/或低骨骼肌放射性密度(SMD)水平。
住院时间、任何并发症(≥1 个预先定义的并发症)或主要并发症(Clavien-Dindo 分类评分≥3)、30 天死亡率和出院后 30 天内再入院以及总死亡率。
诊断时的平均(SD)年龄为 64.0(11.3)岁,906 人(55.6%)为女性。低 SMI 或低 SMD 的患者在手术后住院 7 天或更长时间的可能性更高(优势比 [OR],1.33;95% CI,1.05-1.68;OR,1.39;95% CI,1.05-1.84),并且整体死亡率的风险更高(风险比,1.40;95% CI,1.13-1.74;风险比,1.44;95% CI,1.12-1.85)。此外,低 SMI 患者更有可能发生 1 次或多次术后并发症(OR,1.31;95% CI,1.04-1.65),并且 30 天死亡率的风险更高(OR,4.85;95% CI,1.23-19.15)。低 SMD 与发生主要并发症的几率较高相关(OR,2.41;95% CI,1.44-4.04)。
低 SMI 和低 SMD 与 LOS 延长、术后并发症风险增加以及短期和长期死亡率增加有关。研究应评估是否可以在术前针对潜在可改变的因素(例如保留肌肉质量),从而改变与术后结果相关的观察到的负面关联。